Titan Pharmaceuticals Reports $763K Q3 Net Loss
Titan Pharmaceuticals reveals a $763,000 net loss in Q3, translating to a 83 cents per share loss. Discover the impact on Titan's financial performance.
Topic
net loss
A collection of 1 issue